Holen Sie sich die Stockscreener-App
3.515
3.99%
0.135
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt MNKD?
Forum
Prognose
Aktiensplit
Schlusskurs vom Vortag:
$3.38
Offen:
$3.43
24-Stunden-Volumen:
2.19M
Relative Volume:
0.33
Marktkapitalisierung:
$1.09B
Einnahmen:
$348.97M
Nettoeinkommen (Verlust:
$5.86M
KGV:
209.23
EPS:
0.0168
Netto-Cashflow:
$13.69M
1W Leistung:
+18.75%
1M Leistung:
+30.19%
6M Leistung:
-34.67%
1J Leistung:
-14.68%
1-Tages-Spanne:
$3.415
$3.54
1-Wochen-Bereich:
$2.99
$3.54
52-Wochen-Spanne:
$2.23
$6.51
Mannkind Corp Stock (MNKD) Company Profile
Firmenname
Mannkind Corp
Sektor
Branche
Telefon
818-661-5000
Adresse
1 CASPER STREET, DANBURY, CA
Compare MNKD vs VRTX, REGN, ARGX, ALNY, RVMD
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
MNKD
Mannkind Corp
|
3.52 | 1.04B | 348.97M | 5.86M | 13.69M | 0.0168 |
VRTX
Vertex Pharmaceuticals Inc
|
436.52 | 110.28B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
634.88 | 66.98B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
806.13 | 50.15B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
294.74 | 39.71B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
154.40 | 32.22B | 742.00K | -1.37B | -1.07B | -7.0731 |
Mannkind Corp Stock (MNKD) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-02-27 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
| 2025-11-24 | Eingeleitet | Truist | Buy |
| 2025-11-13 | Eingeleitet | Leerink Partners | Outperform |
| 2025-10-20 | Eingeleitet | Wells Fargo | Overweight |
| 2025-10-10 | Eingeleitet | Leerink Partners | Outperform |
| 2025-07-16 | Fortgesetzt | H.C. Wainwright | Buy |
| 2025-04-10 | Eingeleitet | Mizuho | Outperform |
| 2025-02-10 | Eingeleitet | Wedbush | Outperform |
| 2024-12-20 | Eingeleitet | Wells Fargo | Overweight |
| 2024-12-19 | Hochstufung | RBC Capital Mkts | Sector Perform → Outperform |
| 2024-09-09 | Fortgesetzt | Leerink Partners | Outperform |
| 2024-06-13 | Eingeleitet | Rodman & Renshaw | Buy |
| 2023-10-10 | Eingeleitet | Wedbush | Outperform |
| 2021-05-14 | Eingeleitet | RBC Capital Mkts | Sector Perform |
| 2019-12-24 | Eingeleitet | Oppenheimer | Outperform |
| 2019-10-25 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2019-05-14 | Eingeleitet | BTIG Research | Buy |
| 2019-03-04 | Eingeleitet | SVB Leerink | Outperform |
| 2019-02-22 | Eingeleitet | SVB Leerink | Outperform |
| 2018-02-28 | Herabstufung | Maxim Group | Hold → Sell |
| 2017-11-01 | Herabstufung | Maxim Group | Buy → Hold |
| 2017-10-10 | Eingeleitet | H.C. Wainwright | Buy |
| 2017-10-06 | Bestätigt | Maxim Group | Buy |
| 2017-08-11 | Eingeleitet | Maxim Group | Buy |
| 2016-05-10 | Bestätigt | Piper Jaffray | Underweight |
| 2016-05-10 | Bestätigt | RBC Capital Mkts | Underperform |
| 2016-01-06 | Bestätigt | Piper Jaffray | Underweight |
| 2016-01-06 | Bestätigt | RBC Capital Mkts | Underperform |
| 2015-11-04 | Herabstufung | RBC Capital Mkts | Outperform → Underperform |
| 2015-09-09 | Herabstufung | Piper Jaffray | Neutral → Underweight |
| 2015-08-03 | Bestätigt | RBC Capital Mkts | Outperform |
| 2015-05-11 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2015-05-11 | Bestätigt | MLV & Co | Hold |
| 2015-04-16 | Bestätigt | RBC Capital Mkts | Outperform |
Alle ansehen
Mannkind Corp Aktie (MNKD) Neueste Nachrichten
MannKind Corporation 8-K Filing Details Board Election Results and Company Information (May 2026) - Minichart
Director Michael A. Friedman awarded 82,781 MannKind (MNKD) restricted stock units - Stock Titan
MannKind director (MNKD) awarded stock and RSUs, updates holdings - Stock Titan
MannKind (MNKD) director Jennifer Grancio granted 82,781 restricted stock units - Stock Titan
MannKind (MNKD) HR chief adds 33,898 shares under stock purchase plan - Stock Titan
MannKind shareholders elect directors and approve proposals at annual meeting - Investing.com
MannKind (NASDAQ: MNKD) reports 2026 annual meeting voting results - Stock Titan
MNKD stock records biggest single-day gains in over 5 years, breaches a key technical milestone – what’s driving this rally? - MSN
MannKind Corp stock (US5638651064): inhaled insulin specialist draws attention after recent business - AD HOC NEWS
MannKind Corp stock (US5638651064): focus on Afrezza growth and partnership pipeline - AD HOC NEWS
MNKD Technical Analysis | Trend, Signals & Chart Patterns | MANNKIND CORP (NASDAQ:MNKD) - ChartMill
FY2026 EPS Estimates for MannKind Increased by HC Wainwright - MarketBeat
MannKind Corp. (MNKD) Reports Q1 2026 Total Revenues of $90.2M - Insider Monkey
MannKind Corp stock (US5638651064): respiratory drug specialist in focus after latest quarterly upda - AD HOC NEWS
5 Best NASDAQ Stocks Under $5 to Buy Right Now - Insider Monkey
MNKD (NASDAQ) amendment shows RSU resale filing via Morgan Stanley - Stock Titan
MannKind Corp stock (US5638651064): Biopharma innovator in inhaled therapies - AD HOC NEWS
MannKind EVP David Thomson sells $9,978 in company stock By Investing.com - Investing.com Australia
Mannkind director Steven Binder sells $55,732 MNKD stock - Investing.com
MannKind EVP David Thomson sells $9,978 in company stock - Investing.com India
Mannkind director Steven Binder sells $55,732 MNKD stock By Investing.com - Investing.com Nigeria
MANNKIND CORP (MNKD) officer has shares withheld to cover RSU taxes - Stock Titan
MannKind (MNKD) EVP trades shares under pre-set Rule 10b5-1 plan - Stock Titan
Wells Fargo Raises its Price Target on MannKind (MNKD) to $10 - Insider Monkey
[144] MANNKIND CORP SEC Filing - Stock Titan
10 Best Penny Stocks to Buy Before They Explode - Insider Monkey
State Street (NASDAQ: MNKD) holds 18.68M shares, 6.1% stake - Stock Titan
MannKind Corp stock (US5638651064): Q1 2026 earnings miss on EPS, revenue up 15% - AD HOC NEWS
The $59B Quiet Shift Reshaping How Patients Access Care - Benzinga
H.C. Wainwright and Wells Fargo Lift MannKind (MNKD) Price Targets - Insider Monkey
TradingKey - TradingKey
5 Best US Stocks Under $5 to Buy - Insider Monkey
MNKD Technical Analysis & Stock Price Forecast - Intellectia AI
MNKD Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
Q1 2026 MannKind Corp Earnings Call Transcript - GuruFocus
Wall Street Zen Downgrades MannKind (NASDAQ:MNKD) to Sell - MarketBeat
MannKind (MNKD) CEO clarifies 100,000-share Form 4 error in amendment - Stock Titan
MannKind (MNKD) Is Up 25.4% After Mixed Q1 Results and Expanded United Therapeutics Partnership – What's Changed - Yahoo Finance
MNKD Maintained by RBC Capital -- Price Target Raised to $4.75 - GuruFocus
MNKD Maintains Overweight Rating -- Price Target Raised to $10.0 - GuruFocus
MannKind Corporation (NASDAQ:MNKD) Q1 2026 Earnings Call Transcript - Insider Monkey
MannKind Q1 2026 slides: revenue up 15%, three catalysts ahead By Investing.com - Investing.com Canada
MannKind (NASDAQ:MNKD) Announces Earnings Results, Misses Estimates By $0.03 EPS - MarketBeat
MannKind Q1 Earnings Call Highlights - Yahoo Finance
MannKind Corporation Q1 2026 Earnings Call Summary - Yahoo Finance
Finanzdaten der Mannkind Corp-Aktie (MNKD)
Umsatz
Nettogewinn
Free Cashflow
ENV
Mannkind Corp-Aktie (MNKD) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Thomson David | EVP Genl Counsel & Secretary |
May 12 '26 |
Sale |
3.29 |
3,033 |
9,979 |
826,299 |
2.25%
0.46%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):